274 related articles for article (PubMed ID: 18199095)
1. L-carnitine supplementation in the dialysis population: are Australian patients missing out?
Reuter SE; Faull RJ; Evans AM
Nephrology (Carlton); 2008 Feb; 13(1):3-16. PubMed ID: 18199095
[TBL] [Abstract][Full Text] [Related]
2. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
Steinman TI
Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
[TBL] [Abstract][Full Text] [Related]
3. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
4. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
[TBL] [Abstract][Full Text] [Related]
5. Carnitine replacement in end-stage renal disease and hemodialysis.
Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
[TBL] [Abstract][Full Text] [Related]
6. Advances in carnitine in chronic uremia.
Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
[TBL] [Abstract][Full Text] [Related]
7. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
[No Abstract] [Full Text] [Related]
8. Dialysis-related carnitine disorder.
Hedayati SS
Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
[TBL] [Abstract][Full Text] [Related]
9. Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.
Canavese C; Petrarulo M; Massarenti P; Berutti S; Fenoglio R; Pauletto D; Lanfranco G; Bergamo D; Sandri L; Marangella M
Am J Kidney Dis; 2005 Mar; 45(3):540-9. PubMed ID: 15754276
[TBL] [Abstract][Full Text] [Related]
10. Carnitine and hemodialysis.
Bellinghieri G; Santoro D; Calvani M; Mallamace A; Savica V
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S116-22. PubMed ID: 12612967
[TBL] [Abstract][Full Text] [Related]
11. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis.
Berns JS; Mosenkis A
Hemodial Int; 2005 Jan; 9(1):7-22. PubMed ID: 16191049
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
[TBL] [Abstract][Full Text] [Related]
14. The effects of L-carnitine therapy on respiratory function tests in chronic hemodialysis patients.
Bavbek N; Akay H; Uz B; Uz E; Turgut F; Kanbay M; Senes M; Akcay A; Duranay M
Ren Fail; 2010 Jan; 32(2):157-61. PubMed ID: 20199175
[TBL] [Abstract][Full Text] [Related]
15. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
Schreiber BD
Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
[TBL] [Abstract][Full Text] [Related]
16. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.
Sakurauchi Y; Matsumoto Y; Shinzato T; Takai I; Nakamura Y; Sato M; Nakai S; Miwa M; Morita H; Miwa T; Amano I; Maeda K
Am J Kidney Dis; 1998 Aug; 32(2):258-64. PubMed ID: 9708610
[TBL] [Abstract][Full Text] [Related]
17. Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
Di Iorio BR; Guastaferro P; Cillo N; Cucciniello E; Bellizzi V
Nephrol Dial Transplant; 2007 Mar; 22(3):954-5; author reply 955-6. PubMed ID: 17132710
[No Abstract] [Full Text] [Related]
18. L-carnitine supplementation in dialysis: treatment in quest of disease.
Wasserstein AG
Semin Dial; 2013; 26(1):11-5. PubMed ID: 23173999
[TBL] [Abstract][Full Text] [Related]
19. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease.
Reuter SE; Evans AM; Faull RJ; Chace DH; Fornasini G
Ann Clin Biochem; 2005 Sep; 42(Pt 5):387-93. PubMed ID: 16168195
[TBL] [Abstract][Full Text] [Related]
20. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
Schiffl H; Lang SM
Nephrol Dial Transplant; 2006 Jan; 21(1):133-7. PubMed ID: 16144854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
